BLLN BillionToOne (BLLN) Q1 FY26 earnings call
BillionToOne delivered a strong first quarter, marked by significant revenue growth and expanded profitability, driven by product innovation and commercial execution. The company launched Unity Confirm, a novel noninvasive fetal cell-based confirmation assay, further differentiating its prenatal offerings. Management raised full-year revenue guidance, primarily reflecting Q1 strength and anticipated ASP benefits from new payer contracts, while maintaining a focus on profitability and cash flow generation.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
BLLN operating KPIs by quarter
| KPI | Dec 2025 Q4 FY25 | This call Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|
| Procedures | ~170KOur leadership in product innovation and our growing commercial team continue to drive our test volume with Q4 reaching approximately 170,000 tests, a 47% year-over-year increase.Source: earnings call transcript | ~188KIn Q1, we delivered approximately 188,000 tests, representing 44% year-over-year growth and strong sequential growth across both product lines, with prenatal volumes growing approximately 10% quarter-over-quarter and oncology volumes growing approximately 25% quarter-over-quarter.Source: earnings call transcript | — | — |
| Average selling price | $561Overall ASP increased another 12% quarter-over-quarter from $501 to $561, a significant $60 per test increase in a single quarter.Source: earnings call transcript | $571As our ASPs increased 28% year-over-year to $571 per test and as we maintained our COGS at $153 per test despite the higher proportion of oncology tests that have a higher COGS, we expanded our gross margins to 73% in Q1, a strong 9 percentage point increase year-over-year.Source: earnings call transcript | $551Overall ASP increased 21% year-over-year to $551 per test.Source: earnings call transcript | -3.5% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.